Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.76 Insider Own2.51% Shs Outstand244.93M Perf Week1.77%
Market Cap281.67M Forward P/E- EPS next Y-0.73 Insider Trans471.44% Shs Float238.79M Perf Month-14.18%
Income-157.86M PEG- EPS next Q-0.20 Inst Own77.13% Short Float / Ratio9.37% / 9.14 Perf Quarter-31.95%
Sales0.53M P/S531.45 EPS this Y-29.03% Inst Trans20.01% Short Interest22.37M Perf Half Y-58.11%
Book/sh0.57 P/B2.03 EPS next Y8.75% ROA-67.44% Target Price5.72 Perf Year-46.26%
Cash/sh0.89 P/C1.29 EPS next 5Y- ROE-111.35% 52W Range0.92 - 3.79 Perf YTD-39.79%
Dividend- P/FCF- EPS past 5Y12.05% ROI-64.64% 52W High-69.65% Beta1.05
Dividend %- Quick Ratio6.91 Sales past 5Y26.76% Gross Margin1.13% 52W Low25.00% ATR0.10
Employees135 Current Ratio6.92 Sales Q/Q315.38% Oper. Margin-29245.01% RSI (14)50.41 Volatility7.05% 8.86%
OptionableYes Debt/Eq0.76 EPS Q/Q-54.30% Profit Margin-29728.25% Rel Volume0.87 Prev Close1.06
ShortableYes LT Debt/Eq0.75 EarningsNov 08 BMO Payout- Avg Volume2.45M Price1.15
Recom2.33 SMA200.07% SMA500.87% SMA200-42.31% Volume2,133,264 Change8.49%
Date Action Analyst Rating Change Price Target Change
Mar-07-23Initiated Jefferies Hold $3
Aug-12-22Initiated Piper Sandler Overweight $10
Jan-29-21Upgrade JP Morgan Underweight → Neutral $7
Jan-29-21Downgrade Wedbush Outperform → Neutral $2 → $8
Dec-08-20Upgrade Citigroup Neutral → Buy
Nov-18-20Upgrade Gabelli & Co Hold → Buy
Dec-11-19Downgrade Gabelli & Co Buy → Hold
Nov-08-19Downgrade Citigroup Buy → Neutral $3 → $4
Sep-11-19Upgrade Gabelli & Co Hold → Buy $3
Jul-29-19Downgrade Stifel Buy → Hold $10 → $4
Nov-30-23 07:30AM
Nov-22-23 07:30AM
Nov-15-23 01:03AM
Nov-12-23 02:10PM
Nov-10-23 04:01PM
10:53AM Loading…
Nov-08-23 09:45PM
Nov-03-23 09:00AM
Nov-02-23 09:00AM
Nov-01-23 09:00AM
Oct-31-23 04:01PM
Oct-30-23 04:01PM
Oct-25-23 08:45AM
04:01PM Loading…
Oct-17-23 04:01PM
Oct-13-23 11:38AM
Oct-11-23 11:13AM
Oct-10-23 11:25AM
Oct-09-23 04:01PM
Sep-28-23 09:00AM
Sep-26-23 09:00AM
Sep-20-23 12:28PM
Sep-14-23 09:40PM
Sep-07-23 04:30PM
09:00AM Loading…
Aug-21-23 09:00AM
Aug-17-23 09:56AM
Aug-08-23 09:00AM
Aug-04-23 09:12AM
Aug-03-23 05:15PM
Jul-28-23 04:01PM
Jun-30-23 06:52AM
Jun-27-23 06:46AM
Jun-23-23 08:45PM
Jun-20-23 08:00AM
Jun-15-23 05:00PM
Jun-06-23 04:01PM
Jun-05-23 04:01PM
Jun-04-23 07:00AM
Jun-02-23 09:21AM
Jun-01-23 11:35AM
May-31-23 04:01PM
May-26-23 04:25PM
May-22-23 07:33AM
May-11-23 06:50AM
May-10-23 04:30PM
May-04-23 10:05AM
May-03-23 11:45AM
May-02-23 04:00PM
Apr-28-23 04:00PM
Apr-22-23 08:15AM
Apr-21-23 09:00AM
Apr-17-23 04:00PM
Mar-06-23 06:00AM
Mar-04-23 12:00PM
Mar-03-23 07:07AM
Mar-02-23 04:00PM
Feb-28-23 05:00PM
Feb-20-23 08:00AM
Feb-01-23 07:56AM
Jan-06-23 04:05PM
Dec-29-22 06:52PM
Dec-22-22 09:22AM
Dec-21-22 04:30PM
Nov-28-22 08:00AM
Nov-15-22 10:00AM
Nov-14-22 04:03PM
Nov-12-22 07:28AM
Nov-11-22 08:58AM
Nov-09-22 04:01PM
Nov-08-22 08:58AM
Nov-06-22 05:29PM
Nov-05-22 10:35AM
Nov-04-22 08:58AM
Oct-31-22 08:59AM
Oct-24-22 08:59AM
Oct-02-22 01:00PM
Sep-20-22 08:59AM
Aug-22-22 04:05PM
Aug-05-22 04:59PM
Aug-02-22 04:01PM
Jul-29-22 08:00AM
Jul-28-22 07:00AM
Jul-27-22 04:01PM
Jun-29-22 04:01PM
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COATS LONNELChief Executive OfficerNov 16Buy1.0590,00094,797914,359Nov 17 04:55 PM
COATS LONNELChief Executive OfficerNov 10Buy1.0110,00010,100824,359Nov 13 05:31 PM
DEBBANE RAYMONDDirectorOct 12Buy1.03148,820153,8051,340,847Oct 12 04:01 PM
DEBBANE RAYMONDDirectorOct 11Buy1.08342,874370,7841,192,027Oct 12 04:01 PM
DEBBANE RAYMONDDirectorOct 10Buy1.14508,306579,367849,153Oct 12 04:01 PM
WADE JEFFREY LPresident and CFOSep 14Buy1.3810,00013,800264,341Sep 14 05:05 PM
McDermott WendyVP, Human ResourcesAug 04Buy1.846,00011,04028,478Aug 07 04:13 PM
COATS LONNELChief Executive OfficerJun 29Buy2.1610,00021,600814,359Jun 29 04:13 PM
COATS LONNELChief Executive OfficerJun 26Buy2.1810,00021,792804,359Jun 26 04:04 PM
COATS LONNELChief Executive OfficerJun 23Buy2.5010,00024,950794,359Jun 26 04:04 PM
McDermott WendyVP, Human ResourcesJun 23Buy2.4310,00024,30022,478Jun 27 04:22 PM
COATS LONNELChief Executive OfficerJun 22Buy2.3140,00092,400784,359Jun 22 04:01 PM
WADE JEFFREY LPresident and CFOJun 20Buy2.3312,00028,000254,341Jun 20 04:10 PM
Artal International S.C.A.DirectorJun 05Buy2.6027,775,05072,215,13078,634,381Jun 05 04:46 PM
Swain Judith LDirectorMay 21Option Exercise0.009,302040,332May 22 04:07 PM
Palantoni FrankDirectorMay 21Option Exercise0.009,302040,332May 22 04:06 PM
SOBECKI CHRISTOPHER JDirectorMay 21Option Exercise0.009,3020159,023May 22 04:06 PM
NIES ALAN SDirectorMay 21Option Exercise0.009,302041,046May 22 04:05 PM
DEBBANE RAYMONDDirectorMay 21Option Exercise0.009,3020340,847May 22 04:03 PM
LEFKOWITZ ROBERT J MDDirectorMay 21Option Exercise0.009,302040,332May 22 04:04 PM
BARKER SAM LDirectorMay 21Option Exercise0.009,302079,617May 22 04:02 PM
Amouyal PhilippeDirectorMay 21Option Exercise0.009,302040,332May 22 04:01 PM